1. Risankizumab shows faster response in bio naïve than in bio‐experienced psoriatic patients. (22nd June 2022) Authors: Mastorino, L.; Castelli, F.; Stroppiana, E.; Verrone, A.; Ortoncelli, M.; Susca, S.; Boskovic, S.; Passerini, S.G.; Macagno, N.; Cariti, C.; Licciardello, M.; Solaroli, C.; Pertusi, G.; Aragone, M.G.; Baggini, G.; Addese, C.; Leporati, C.; Peila, R.; Giura, M.T.; Rossotto, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 10(2022) Page Start: e838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗